Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

ARON

Financiado

Cerrado

Assay Ready Organ Network

In drug development, there is an urgent need for more physiological and predictive pre-clinical in-vitro assays to test the efficacy and toxicity of compounds. This to allow new medicines to be brought to the market quicker and sa... ver más

30/06/2020

INSPHERO

71K€

Presupuesto del proyecto: 71K€

Líder del proyecto

INSPHERO AG No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 2 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2020-06-30

EIC-SMEInst-2018-2020: SME instrument

I+D

Cerrada hace 7 años

0% 70% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

2 Participantes

INSPHERO

50.00K€ | Lider

PIGRA ENGINEERING

254.64K€ | Participante

Proyectos interesantes

PTQ-13-06222

Medical Technol...

Materials Scien...

111K€ Cerrado

PDC2022-133755-I00

Medical Technol...

Nanotechnology

115K€ Cerrado

SPECCC

Medical Technol...

Materials Scien...

1M€ Cerrado

BOC

Medical Technol...

Biotechnology

2M€ Cerrado

PANBioRA

Medical Technol...

Materials Scien...

8M€ Cerrado

3DProSeed

Medical Technol...

Biotechnology

71K€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 6 meses Fecha Inicio: 2019-12-06
Fecha Fin: 2020-06-30

Líder del proyecto

INSPHERO AG No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 71K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto In drug development, there is an urgent need for more physiological and predictive pre-clinical in-vitro assays to test the efficacy and toxicity of compounds. This to allow new medicines to be brought to the market quicker and safer. With the growing biological complexity of today’s diseases, it is vital to have interconnected 3D tissue structures of multiple organs in order to investigate biological cross-talk. Today, such physiological and predictive pre-clinical in-vitro assays are not available. Here, InSphero presents ARON, their Assay-Ready Organ Network, to address the urgent need for more physiological and predictive pre-clinical in-vitro assays and aims to study the feasibility of a successful market introduction. ARON is the most advanced modular in-vitro assay platform and will set a new standard for a wide range of cell-based pre-clinical testing by shifting the organ-on-a-chip technology from a late-stage, luxury service to routinely used ready-to-use assays. This enables pharma and biotech companies to develop drugs in a faster and more efficient way, without the use of animals. All elements and process steps guarantee routine implementation for everyone, while experimental complexity is minimized. ARON has the unique option that the consumables are assay-ready, directly shipped on-site, on-demand, and worldwide. InSphero is a leading supplier of organotypic in-vitro 3D microtissues for predictive drug testing and has grown yearly by 40% in the past years. ARON will turn today's service possibilities into a scalable product and will enable to offer assays for highly competitive pricing. The (USA dominated) 3D tissue market is expected to grow with CAGR of 63% to reach a market size of 1.5 billion EUR in 2024. A successful market introduction will impact the EU’s society and economy by creating hundreds of jobs, accelerating drug development that will improve the health of EU-citizens, while reducing cost, time-to-market and the need for animal testing

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores